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doi:10.1Objectives: Patients with congenital bicuspid aortic valves have aortic valve stenosis at a relatively young age
compared with patients with tricuspid aortic valves. We hypothesize that aortic valve stenosis evolves from
a more aggressive inflammatory process, with increased macrophage/T-cell and neovessel content in congenital
bicuspid aortic valveswhen compared with that seen in tricuspid valves.
Methods: Fifty-one severely stenotic aortic valves were obtained at the time of aortic valve replacement. A total
of 17 bicuspid and 34 tricuspid aortic valves were evaluated. Macrophage/T-cell infiltration (CD68 plus CD3)
and neovessel density (CD34) were evaluated with immunohistochemical staining. Leaflet calcification and os-
sification were also quantified. Real-time polymerase chain reaction was used to assess expression of chondro-
modulin 1 and vascular endothelial growth factor.
Results: The density of macrophages/T cells was greater in congenital bicuspid aortic valves than in tricuspid
valves (51  31 vs 23  13 cells/mm2, P ¼ .002). Neovascularization was more frequently noted in congenital
bicuspid aortic valves when compared with tricuspid valves (31  10 vs 21  9 vessels/mm2, P ¼ .0005), and
calcification was more severe (P¼ .03). Expression of chondromodulin 1 demonstrated a 6-fold downregulation
(P ¼ .0003) and expression of vascular endothelial growth factor demonstrated a 2-fold increase (P ¼ .02) in
congenital bicuspid aortic valves compared with that seen in tricuspid valves. Multivariable analyses demon-
strated significant associations between bicuspid aortic valve anatomy and increased inflammatory cell infiltra-
tion (b¼ 25.8, P¼ .0007) and neovascularization (b¼ 9.4,P¼ .001), despite adjusting for measured covariates.
Conclusions: The pathogenesis of aortic valve stenosis in bicuspid aortic valves is associated with a more ag-
gressive inflammatory process with increased macrophage infiltration and neovascularization when compared
with that seen in tricuspid valves. (J Thorac Cardiovasc Surg 2011;142:895-901)A congenital bicuspid aortic valve (CBAV) is one of the
most common congenital cardiovascular malformations,
occurring in as much as 2% of adults,1 and a large propor-
tion of patients with CBAVs will require valvular interven-
tion for aortic valve stenosis (AS), regurgitation, or
infective endocarditis.2 AS is the most frequent complica-
tion of CBAVs, frequently necessitating aortic valve re-
placement surgery relatively early in life when compared
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ing valve stenosis frequently seen in those with CBAVs.3
To date, few data exist to explain the early development of
AS in patients with CBAVs. The progression of AS in pa-
tients with CBAVs differs based on the symmetry and anat-
omy of the bicuspid valve, suggesting that stress–strain
relations might be responsible for early disease onset and
more rapid progression.3,4 Cardiovascular risk factors, such
as hypercholesterolemia and a history of hypertension,
have been associated with increased risk of AS in those
with CBAVs.5 Significant data are mounting that suggest
that the genetic aberrations that lead to bicuspid anatomy
might also lead to an increased propensity to calcify.6-10
Such data suggest similarities between the mechanisms
responsible for AS in bicuspid and tricuspid aortic valves.
Fibrocalcific AS in TAVs results from an active process
that, much like atherosclerosis, is preceded by basement
membrane disruption, inflammatory cell infiltration,
neovascularization, and lipid deposition and culminates in
severe calcification and bone formation.11-15 Together,
these data suggest that the hemodynamic and cellular
abnormalities associated with CBAVs might intensify the
active processes involved in valve degeneration. Here we
hope to determine whether inflammation, defined byrdiovascular Surgery c Volume 142, Number 4 895
Abbreviations and Acronyms
AS ¼ aortic valve stenosis
BMP ¼ bone morphogenic protein
CBAV ¼ congenital bicuspid aortic valve
ChM-1 ¼ chondromodulin 1
CI ¼ confidence interval
NOTCH1 ¼ NOTCH homologue-1
TAV ¼ tricuspid aortic valve
VEGF ¼ vascular endothelial growth factor
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concomitant calcification, is increased in patients with AS
caused by CBAVs. Additionally, we assess the expression
of chondromodulin 1 (ChM-1), a potent antiangiogenic
factor, and vascular endothelial growth factor (VEGF),
a stimulator of angiogenesis, in stenotic bicuspid aortic
valves and tricuspid aortic valves.
MATERIALS AND METHODS
Study Population and Data Collection
From January to December 2006, 92 patients with severe aortic stenosis
underwent successful aortic valve replacement at the Mount Sinai Medical
Center. All bicuspid valves (n¼ 20) and randomly selected tricuspid valves
(n¼ 34) were selected for further analysis. Valve tissuewas collected at the
time of the operation. Patients’ medical records were reviewed to assess the
prevalence of cardiovascular risk factors and the use of relevant cardiovas-
cular medications. The retrospective review of clinical data was approved
by the Mount Sinai School of Medicine’s Institutional Review Board.
Immunohistochemistry
Four-micrometer serial sections of formalin-fixed, paraffin-embedded
valve tissue were cut for subsequent staining. Tissue sections were deparaf-
finized and pretreated with sodium citrate antigen retrieval for 5-minute in-
tervals up to a total of 15 minutes. After blocking endogenous peroxidase
activity with 10% hydrogen peroxide in methanol, sections were subjected
to double labeling. Primary monoclonal murine anti-human antibodies of
IgG1 class (DAKOCorp, Carpinteria, Calif) included the CD34 endothelial
cloneQbend-10 at 1:30 dilution, the CD68macrophage cloneKP-1 at 1:100
dilution/CD3 T lymphocyte clone at 1:50 dilution, and the a-actin smooth
muscle clone at 1:50 dilution. Affinity-purified secondary anti-mouse IgG
antibodies withWestern blotting–confirmed specificity were obtained from
Vector Laboratories (Burlingame, Calif) as the Avidin-Biotin Conjugated
Elite kit PK6102. Double immunohistochemistry was systematically per-
formed in all sections by applying 2 entirely separate sets of contrasting bi-
color preparations to each block. The first paired bicolor preparation used
blue (alkaline phosphatase SK 5300 Vector) and red (alkaline phosphatase
SK 5100 Vector) chromogen reaction to distinguish endothelial microves-
sel cells from inflammatory cells (macrophage–lymphocyte cocktail), re-
spectively. Specificity of all antibodies was confirmed by means of
routine positive and negative controls for each stain by using human tonsil
and bowel tissue to exclude nonspecific binding of the primary antibody.
Macrophages and T lymphocytes were defined as CD68þ/CD3þmono-
nuclear round cells identified by means of light microscopy, as previously
described.16 Neovessels were defined as tubuloluminal CD34þ capillaries
recognized in cross-sectional and longitudinal profiles, as previously de-
scribed.17 The aortic valve specimen was systematically examined in 10
random microscopic fields and sequentially planimetered by means of896 The Journal of Thoracic and Cardiovascular Surgdedicated image-processing software (Quantim; Zedec Technologies,
Burlington, NC) at 403magnification, as previously described.18 The den-
sity of inflammatory cell infiltration and of neovessels was determined by
dividing the number of inflammatory cells and neovessels per field by the
individual area examined. Mean density was calculated for each specimen
and used for subsequent analyses. Calcification was graded on a scale of 1
to 4, as previously described.19 Briefly, grade 1 valves possessed no calci-
fication, grade 2 valves possessed early calcific nodules, grade 3 valves pos-
sessed several calcific nodules with mild structural distortion, and grade 4
valves possessed many calcific nodules with severe structural distortion.
Ossification was identified by means of osteoid matrix deposition or lamel-
lar bone formation12 and was analyzed as a dichotomous variable. All mea-
surements were performed blind to valve morphology.
Gene Expression
An Arcturus Paradise Plus Whole Transcript RT kit (MDS Analytical
Technologies, Sunnyvale, Calif) was used to isolate RNA from formalin-
fixed paraffin-embedded tissue samples, as we have previously described.20
Briefly, the tissue sections were deparaffinized with xylene and then di-
gested with proteinase K for 16 to 20 hours at 37C in an oven. Total
RNAwas then isolated with the Paradise reagent system (MDS Analytical
Technologies). The quality of the isolated RNAwas verified with the Par-
adise sample quality assessment kit (MDS Analytical Technologies), and
the concentration of RNA was quantified with Nanodrop (Thermo Fisher
Scientific, Waltham, Mass). The cDNAwas prepared by using reverse tran-
scriptase polymerase chain reaction. Gene expression of ChM-1 and VEGF
was assessed by using quantitative real-time polymerase chain reaction
with an ABI PRISM 7700 Sequence Detection System (Applied Biosys-
tems, Foster City, Calif). Specific primer pairs for ChM-1 used were as
follows: forward 50-tcagcctgtgaaggacaaca-30 and reverse 50-taggaaggt
caccgcagagt-30 and for VEGF were forward 50-ctacctccaccatgccaagt-30
and reverse 50-atgattctgccctcctcctt-3. The mRNA expression of these genes
was normalized to that of the housekeeping gene b-actin.
Statistical Analysis
All data are presented as means  standard deviations. For 2-group
comparisons, Gaussian samples were compared by using the 2-tailed Stu-
dent t test preceded by Levene’s F test for equality of variance. Non-
Gaussian samples were compared with the Mann–Whitney nonparametric
test. Fisher’s exact test was used to test the significance of association for
discrete variables. Multivariable linear regressionmodeling was used to ad-
just for suspected confounders. Given our small sample size, we limited
multivariable models to 6 covariates. The most relevant covariates were se-
lected for inclusion in multivariable models based on a priori clinical
knowledge. Statistical analyses were performed with SAS software (ver-
sion 9.1.3; SAS Institute, Inc, Cary, NC). Two-sided P values of less
than .05 were considered statistically significant.
RESULTS
Patients’ Characteristics
A total of 51 patients were included in this analysis
(Table 1). Three bicuspid valves were excluded because of
either rheumatic valve disease or infectious endocarditis.
The study population included 31 (61%) men. The overall
mean agewas 68 10 years. Nineteen (37%) of the patients
were diabetic, 45 (88%) had hypertension, and 38 (75%)
had hypercholesterolemia. Coronary artery diseasewas pres-
ent in 33 (65%), with 22 (57%) undergoing coronary artery
bypass surgery. Chronic kidney disease was present in 9
(18%) patients. Hydroxymethyl-glutaryl coenzyme A re-
ductase inhibitors (statins) were used in 29 (57%) patients,ery c October 2011
TABLE 1. Clinical and demographic characteristics of patients with bicuspid and tricuspid aortic stenosis
All patients, n (% [n ¼ 51]) Bicuspid, n (% [n ¼ 17]) Tricuspid, n (% [n ¼ 34]) P value
Age (y) 68  10 56  8 67  10 .0004
Female sex 20 (39) 3 (18) 17 (50) .03
Risk factors
Hypertension 45 (88) 15 (88) 30 (88) 1
Hypercholesterolemia 38 (75) 13 (76) 25 (78) 1
Diabetes mellitus 19 (37) 6 (35) 13 (38) 1
Chronic kidney disease 9 (18) 2 (12) 7 (21) .70
Tobacco use 24 (47) 12 (70) 12 (35) .04
Coronary artery disease
Angiography 33 (65) 10 (59) 23 (68) .55
Coronary bypass surgery 29 (57) 9 (52) 20 (59) .77
Medical therapy
Statin 29 (57) 10 (59) 19 (56) 1
ACEI 24 (47) 8 (47) 16 (47) 1
ARB 9 (18) 2 (12) 7 (21) .70
Echocardiographic parameters
LVEF (%) 51  12 53  11 51  13 .56
AVA (cm2) 0.78  0.2 0.84  0.3 0.75  0.2 .31
Mean gradient (mm Hg) 47  20 46  21 47  20 .88
Aortic root diameter (cm) 3.1  0.4 3.2  0.5 3.0  0.4 .22
ACEI, Angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVEF, left ventricular ejection fraction; AVA, aortic valve area.
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(47%) patients, and angiotensin II receptor blockers were
used in 9 (18%) patients.
When stratified by valve morphology, patients with bi-
cuspid and tricuspid aortic valves were comparable, with
a few notable exceptions. As expected, patients with
CBAVs were younger than patients with a tricuspid valves
(61  8 vs 71  10 years, P ¼ .0004). In concert with prior
epidemiologic data,2 patients with CBAVs were more often
men (82% vs 50%, P ¼ .03). Additionally, a significantly
greater prevalence of tobacco use was seen in patients
with CBAVs compared with that seen in those with TAVs
(70% vs 35%, respectively; P ¼ .04).
Echocardiographic Measurements
In all included patients the mean left ventricular ejection
fraction was 51%  12%. The mean aortic valve area was
0.78  0.23 cm2, and the mean transvalvular gradient was
47  20 mm Hg. When comparing patients with CBAVs
and those with TAVs, no significant differences in echocar-
diographic measures of aortic stenosis severity were
observed.
Histopathologic Assessment
The severity of inflammatory cell infiltration and neovas-
cularization differed significantly between patients with
CBAVs and those with TAVs (Figure 1). The density of
macrophages/T cells was greater in patients with CBAVs
compared with that seen in those with TAVs (51  31 vs
23 13 cells/mm2; P¼ .002; Figure 2, A). Neovasculariza-The Journal of Thoracic and Cation was also more frequently noted in patients with CBAVs
when compared with those with TAVs (31  10 vs 21  9
vessels/mm2; P ¼ .0005; Figure 2, B). Valve calcification
was present in all valves, with more severe calcification
noted in CBAVs (P ¼ .03, Table 2). The proportion of
valves containing ossification was greater in CBAVs, but
this difference was not statistically significant (35% vs
21%, P ¼ .31).
Valve inflammation, as defined by the density of inflam-
matory cell infiltration, demonstrated a positive correlation
with density of neovascularization and extent of valve cal-
cification in both tricuspid (r ¼ 0.49 and P ¼ .003 vs
r ¼ 0.57 and P ¼ .0004, respectively) and bicuspid
(r¼ 0.58 and P¼ .02 vs r¼ 0.53 and P¼ .04, respectively)
valves. Ossified bicuspid valves demonstrated increased in-
flammatory cell infiltration (72  29 vs 40 26 cells/mm2,
P ¼ .04), but this relationship was not seen in tricuspid
valves (30  10 vs 22 14 cells/mm2, P ¼ .13). No signif-
icant relationship was observed between neovascularization
and either extent of calcification or ossification.
Multivariable analyses were performed to minimize the
effects of potential confounders. Despite adjusting for
age, sex, presence of chronic kidney disease, smoking sta-
tus, and use of statins, bicuspid anatomy was strongly asso-
ciated with increased aortic valve inflammatory cell
infiltration (b ¼ 25.8 [95% confidence interval (CI),
11.5–40.0], P ¼ .0007) and neovascularization (b ¼ 9.4
[95% CI, 3.9–14.8], P ¼ .001; Table 3). Significant associ-
ations were also noted between neovascularization and the
presence of chronic kidney disease and male sex (Table 3).rdiovascular Surgery c Volume 142, Number 4 897
FIGURE 1. Immunohistochemical staining of severely stenotic bicuspid and tricuspid aortic valves. Macrophages and T lymphocytes were stained with
anti-CD68/CD3monoclonal antibodies conjugated to a red chromogen (red arrows). Neovessels were selectively stained with a monoclonal antibody to the
endothelial cell marker CD34 conjugated with a blue chromogen (blue arrows). More inflammatory cell infiltration and neovascularization is noted in bi-
cuspid (A and B) compared with tricuspid (C and D) valves. The aortic side of the aortic valve is depicted.
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on both valve inflammation and neovascularization, we
conducted an ad hoc multivariable analysis excluding valve
specimens from patients with chronic kidney disease. De-
spite this exclusion, we found that the association of bicus-
pid aortic valve anatomy with inflammatory cell infiltration
and neovascularization remained relatively unchanged
(b ¼ 25.0 [95% CI, 8.9–41.0] and P ¼ .003 vs b ¼ 11.7
[95% CI, 6.1–17.3] and P ¼ .0002, respectively).
Gene Expression
Because of heavy calcification and formalin fixation, we
were able to extract RNA from only 12 of 51 aortic valves
(6 TAVs and 6 CBAVs). ChM-1 gene expression was signif-
icantly downregulated by more than 6-fold in CBAVs com-
pared with that seen in TAVs (P ¼ .0003; Figure 2, C).
Conversely, VEGF gene expression in bicuspid valves
was approximately twice that seen in tricuspid valves
(P ¼ .02; Figure 2, D).
DISCUSSION
This study identified a 122% increase in inflammatory
cell density, a 48% increase in neovascularization, and
more severe calcification in bicuspid valves compared
with tricuspid valves. Bicuspid anatomy was associated
with inflammatory cell infiltration and neovascularization,
despite adjusting for age, sex, chronic kidney disease,
smoking status, and use of statins. Additionally, ChM-1898 The Journal of Thoracic and Cardiovascular Surgexpression was significantly downregulated and VEGF
expression was significantly upregulated in CBAVs, find-
ings in agreement with the discrepant neovascularization
seen on histopathological assessments. These findings sug-
gest that remodeling of CBAVs is associated with a more
aggressive inflammatory process. Although our study does
not allow inference of causality, it does provide useful
insight into the mechanisms at play within the stenotic
bicuspid aortic valve.
Fibrocalcific AS is now known to be the consequence of
an active process similar to that responsible for atheroscle-
rosis. Both are initiated by basement membrane disruption
and lipid deposition and are mediated by inflammatory cell
infiltration and neovascularization.11-13 Moreover, many of
the typical risk factors for atherosclerosis have also been
associated with AS.11 Accelerated progression of AS in pa-
tients with CBAVs has also been associated with atheroscle-
rotic risk factors, suggesting that a similar active process is
involved.5
In patients with atherosclerosis, shear stress plays a role in
endothelial disruption and in plaque size and composition
through modulation of inflammatory chemokines.21,22
Stress–strain relations might similarly play a role in the
accelerated development of AS in patients with CBAVs
given the relationship between rate of progression and
valve symmetry and anatomy.3,4 These data suggest that
increased shear stress in bicuspid valves might modulate
inflammatory processes within the valve, as it does inery c October 2011
FIGURE 2. Inflammation and neovascularization in bicuspid and tricuspid aortic valve specimens. A, The mean density of inflammatory cells (cells per
square millimeter) noted in bicuspid aortic valves was significantly greater than that seen in tricuspid valves (P¼ .002). B, The mean density of neovessels
(vessels per square millimeter) was also significantly greater in bicuspid aortic valves compared with that seen in tricuspid valves (P ¼ .0005). Error bars
denote standard deviations. C, Gene expression of chondromodulin 1, a potent antiangiogenic factor, is significantly downregulated in congenital bicuspid
aortic valves compared with that seen in tricuspid aortic valves (P¼ .0003). D, However, expression of vascular endothelial growth factor (VEFG), which is
proangiogenic, was upregulated in congenital bicuspid aortic valves (P ¼ .02).
Moreno et al Evolving Technology/Basic Scienceatherosclerosis. In fact, recent data from Sucosky and
colleagues23 suggest the presence of a shear stress–induced
inflammatory pathway. Nonphysiologic pulsatile shear
stress stimulated endothelial expression of vascular cell
adhesion molecule 1, intracellular adhesion molecule 1,
bone morphogenic protein (BMP) 4, and transforming
growth factor b1 on the aortic sides of tricuspid porcine
valves. Moreover, Mohler and associates12 demonstrated in-
creased BMP-2 and BMP-4 expression and ossification in
areas adjacent to neovascularization and inflammatory cell
infiltration.
Alternate hypotheses have been proposed to explain the
accelerated calcification seen in CBAVs. Mutations in theTABLE 2. Severity of aortic valve calcification is greater in bicuspid
aortic valves
Severity of
calcification
Bicuspid
(n ¼ 17)
Tricuspid
(n ¼ 34) P value
Grade 1 1 0 .03
Grade 2 1 13
Grade 3 5 7
Grade 4 10 14
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ated with a spectrum of aortic valve disease, including
CBAVs and heavy calcification of TAVs.6,10 NOTCH1
represses calcification pathways mediated by Runx2,
a transcriptional regulator of osteoblastic differentiation,
and BMP-2. Therefore mutations of NOTCH1 lead to de-
regulation of these calcification pathways.6 Additionally,
multiscale computerized modeling of tricuspid and bicus-
pid aortic valves demonstrates that bicuspid valves undergo
greater flexure and stronger jet formation than tricuspid
valves; however, these forces do not transmit to the cellular
and molecular levels.8 As such, it is hypothesized that the
increased structural forces exerted on CBAVs are not capa-
ble of inducing calcific remodeling of the valve and that in-
creased calcification might be due to genetic differences in
matrix components.8 These recent findings suggest that ac-
celerated calcification in CBAVs might be secondary to the
genetic mutation causing the bicuspid morphology.
Whether shear stress, genetic factors, or both are respon-
sible for the observed propensity of CBAVs to calcify, we
found that inflammation and neovascularization are more
severe in stenotic bicuspid valves than in tricuspid valves.
Additionally, we are the first to evaluate ChM-1 expressionrdiovascular Surgery c Volume 142, Number 4 899
TABLE 3. Multivariate analyses of aortic valve inflammation and
neovascularization
Parameter b-Coefficient Standard error P value
Inflammation
Bicuspid anatomy 25.8 7.1 .0007
Age 0.1 0.3 .63
Male sex 10.2 6.4 .12
Chronic kidney disease 12.6 8.5 .15
Statin use 4.3 5.9 .48
Tobacco use 1.2 6.6 .86
Neovascularization
Bicuspid anatomy 9.4 2.7 .001
Age 0.03 0.1 .80
Male sex 5.4 2.5 .03
Chronic kidney disease 14.1 3.3 <.0001
Statin use 0.9 2.3 .70
Tobacco use 0.3 2.5 .92
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that was recently found to play a vital role in maintaining
normal valve function by inhibiting angiogenesis that can
lead to dystrophic valve remodeling.24 Aortic valves from
ChM-1/mice demonstrated increased neovascularization,
VEGF expression, lipid deposition, inflammation, and cal-
cification, suggesting that neovascularization is the first
step in valve degeneration.24 Similar changes have been ob-
served in diseased human valves.11-13,24 Hence the
significant reduction in ChM-1 expression in CBAVs, as
noted in our small exploratory analysis, might be responsi-
ble for the observed increased in neovascularization in
bicuspid valves.
Significant data support an association between neovas-
cularization and inflammatory changes within the aortic
valve with the calcification process.13,25 Monocytes and
macrophages within valves secrete a variety of matrix
proteins that activate valve myofibroblasts and trigger
their osteoblastic transdifferentiation.11 This in part ex-
plains the proximity of inflammatory cells and neovessels
to calcification foci within the valve and supports the notion
that valve inflammation is responsible for subsequent calci-
fication and stenosis.12,25 Here we extend these findings by
demonstrating that stenotic bicuspid valves are associated
with increased inflammatory cell infiltration and
neovascularization when compared with tricuspid valves.
We also demonstrate a positive correlation between valve
inflammation, neovascularization, and the extent of valve
calcification. Although additional data are needed to
establish causality, our findings might help explain the
greater prevalence and accelerated progression of AS and
the increased valve calcification observed in patients with
CBAVs3,9 and might in turn identify angiogenesis as
a potential therapeutic target in patients with CBAVs.
This study reflects histopathological features of the final
stages of calcific AS. As such, our study comments on asso-900 The Journal of Thoracic and Cardiovascular Surgciations among neovascularization, inflammation, and
calcification but cannot definitively distinguish between
cause and effect. Although these findings are useful and
help further our understanding of valve degeneration, they
are to be considered hypothesis generating. More definitive
data on the progression of AS would necessitate histopath-
ological examination of bicuspid and tricuspid aortic valves
at varying stages of disease. Additionally, our study is lim-
ited in that a relatively small number of valves were studied.
As such, we did not possess sufficient statistical power to ad-
just for all potential confounders. Larger studies are needed
to confirm our findings and to further characterize differ-
ences between bicuspid and tricuspid aortic valve disease.
Severe aortic stenosis in bicuspid aortic valves is
associated with a more aggressive inflammatory process
with increased inflammatory cell infiltration and neovascu-
larization when compared with tricuspid AS. These findings
might help explain the more frequent onset and rapid pro-
gression of AS and the heavy aortic valve calcification
seen in patients with CBAVs, although further study is
needed to establish causation. Whether this aggressive in-
flammatory process is more amenable to antiangiogenic
pharmacologic interventions remains to be elucidated.
We thank Dr Carlos Alviar for his assistance with data
collection.
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